Notification of Plasma Product Withdrawals and Recalls; Public Meeting Notice

Summary

The Food and Drug Administration (FDA), the National Heart, Lung, and Blood Institute of the National Institutes of Health (NHLBI), and the Centers for Disease Control and Prevention (CDC) are hosting a public meeting to discuss the withdrawal and recall of plasma-derived products. The meeting aims to inform the public about available resources, discuss the roles of various stakeholders, and gather public input on improving the notification system.